Cargando…

Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies

Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolau, Stefan, Dasgupta, Aneesha, Dasari, Surendra, Charlesworth, M. Cristine, Johnson, Kenneth L., Pandey, Akhilesh, Doles, Jason D., Milone, Margherita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878979/
https://www.ncbi.nlm.nih.gov/pubmed/36703211
http://dx.doi.org/10.1186/s40478-023-01518-9
_version_ 1784878604667060224
author Nicolau, Stefan
Dasgupta, Aneesha
Dasari, Surendra
Charlesworth, M. Cristine
Johnson, Kenneth L.
Pandey, Akhilesh
Doles, Jason D.
Milone, Margherita
author_facet Nicolau, Stefan
Dasgupta, Aneesha
Dasari, Surendra
Charlesworth, M. Cristine
Johnson, Kenneth L.
Pandey, Akhilesh
Doles, Jason D.
Milone, Margherita
author_sort Nicolau, Stefan
collection PubMed
description Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01518-9.
format Online
Article
Text
id pubmed-9878979
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98789792023-01-27 Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies Nicolau, Stefan Dasgupta, Aneesha Dasari, Surendra Charlesworth, M. Cristine Johnson, Kenneth L. Pandey, Akhilesh Doles, Jason D. Milone, Margherita Acta Neuropathol Commun Research Acquired sporadic late onset nemaline myopathy (SLONM) and inherited nemaline myopathy (iNM) both feature accumulation of nemaline rods in muscle fibers. Unlike iNM, SLONM is amenable to therapy. The distinction between these disorders is therefore crucial when the diagnosis remains ambiguous after initial investigations. We sought to identify biomarkers facilitating this distinction and to investigate the pathophysiology of nemaline rod formation in these different disorders. Twenty-two muscle samples from patients affected by SLONM or iNM underwent quantitative histological analysis, laser capture microdissection for proteomic analysis of nemaline rod areas and rod-free areas, and transcriptomic analysis. In all iNM samples, nemaline rods were found in subsarcolemmal or central aggregates, whereas they were diffusely distributed within muscle fibers in most SLONM samples. In SLONM, muscle fibers harboring nemaline rods were smaller than those without rods. Necrotic fibers, increased endomysial connective tissue, and atrophic fibers filled with nemaline rods were more common in SLONM. Proteomic analysis detected differentially expressed proteins between nemaline rod areas and rod-free areas, as well as between SLONM and iNM. These differentially expressed proteins implicated immune, structural, metabolic, and cellular processes in disease pathophysiology. Notably, immunoglobulin overexpression with accumulation in nemaline rod areas was detected in SLONM. Transcriptomic analysis corroborated proteomic findings and further revealed substantial gene expression differences between SLONM and iNM. Overall, we identified unique pathological and molecular signatures associated with SLONM and iNM, suggesting distinct underlying pathophysiological mechanisms. These findings represent a step towards enhanced diagnostic tools and towards development of treatments for SLONM. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01518-9. BioMed Central 2023-01-26 /pmc/articles/PMC9878979/ /pubmed/36703211 http://dx.doi.org/10.1186/s40478-023-01518-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nicolau, Stefan
Dasgupta, Aneesha
Dasari, Surendra
Charlesworth, M. Cristine
Johnson, Kenneth L.
Pandey, Akhilesh
Doles, Jason D.
Milone, Margherita
Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
title Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
title_full Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
title_fullStr Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
title_full_unstemmed Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
title_short Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
title_sort molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878979/
https://www.ncbi.nlm.nih.gov/pubmed/36703211
http://dx.doi.org/10.1186/s40478-023-01518-9
work_keys_str_mv AT nicolaustefan molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT dasguptaaneesha molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT dasarisurendra molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT charlesworthmcristine molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT johnsonkennethl molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT pandeyakhilesh molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT dolesjasond molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies
AT milonemargherita molecularsignaturesofinheritedandacquiredsporadiclateonsetnemalinemyopathies